STTK
Shattuck Labs, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Last price
7.53
▲ 0.28 (3.86%)
MARKET · —
Price
Open
7.60
Prev close
7.25
Day high
7.55
Day low
7.25
Volume
464.23K
Market cap
$755.74M
P/E (TTM)
—
52W range
0.92 – 8.33
Trailing performance
Returnvs SPY
1W
+1.48%
+2.9%
1M
+6.21%
+2.5%
3M
+23.65%
+20.5%
6M
+87.78%
+76.7%
YTD
+106.30%
+94.0%
1Y
+645.54%
+625.5%
3Y
+265.53%
+191.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$755.74M
Enterprise value$550.11M
Revenue (TTM)$1.00M
Gross profit$-38.24M
EBITDA$-52.14M
Net income$-52.57M
EPS (TTM)$-0.44
Free cash flow$-21.22M
Total cash$208.30M
Total debt$2.67M
Book value / share$1.27
Shares outstanding100.36M
Float67.76M
Short % of float6.58%
Dividend yield—
Beta (5Y)1.11
Valuation & profitability ratios
Trailing P/E—
Forward P/E-14.62
PEG ratio—
Price / sales—
Price / book5.94
EV / revenue550.11
EV / EBITDA-10.55
Gross margin0.00%
Operating margin-5570.50%
Profit margin0.00%
Return on equity-39.21%
Return on assets-24.43%
Debt / equity1.27
Current ratio27.59
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $1.00M | $5.72M | $1.66M | $652.00K |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | -$48.81M | -$75.41M | -$87.30M | -$101.94M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$48.81M | -$75.41M | -$87.30M | -$101.94M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.12 | -0.12 | +2.8% |
| Dec 2025 | -0.13 | -0.12 | +11.0% |
| Sep 2025 | -0.14 | -0.14 | +2.8% |
| Jun 2025 | -0.25 | -0.24 | +2.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.12 | 9 | $0 | 0.0% |
| Next quarter | -0.10 | 9 | $0 | 0.0% |
| Current year | -0.47 | 9 | $0 | -100.0% |
| Next year | -0.52 | 9 | $0 | 0.0% |
Analyst targets & ownership
Mean target$14.25
High target$18.00
Low target$10.00
Implied upside89.24%
Analyst count8
ConsensusSTRONG BUY
Strong buy / Buy3 / 7
Hold0
Sell / Strong sell0 / 0
Held by insiders4.08%
Held by institutions80.08%
Institutions holding139
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
+15.85M
Net buying
Buy transactions
15
15.94M shares
Sell transactions
5
85.91K shares
Net transactions
+20
Buys less sells
Sell : buy shares
0.0 : 1
Mixed
Insider-held shares
4.09M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 6, 26 | SHUKLA ABHINAV A. PH.D. Chief Technology Officer |
CONVERSION | 12.56K | $44.85K | Direct |
| Jul 2, 26 | SHUKLA ABHINAV A. PH.D. Chief Technology Officer |
SELL | 410 | $2.87K | Direct |
| Jul 1, 26 | SHUKLA ABHINAV A. PH.D. Chief Technology Officer |
SELL | 23.46K | $166.13K | Direct |
| Jul 1, 26 | SHUKLA ABHINAV A. PH.D. Chief Technology Officer |
CONVERSION | 23.46K | $83.77K | Direct |
| Jun 30, 26 | PANDITE ARUNDATHY N. Officer |
SELL | 30.00K | $210.30K | Direct |
| Jun 9, 26 | SIEGALL CLAY B Director |
BUY | 62.50K | $250.00K | Direct |
| Jun 8, 26 | ASHIYA MONA Director |
CONVERSION | 15.37M | $59.93M | Indirect |
| May 22, 26 | SIEGALL CLAY B Director |
STOCK | 128.05K | $781.13K | Direct |
| May 22, 26 | SIEGALL CLAY B Director |
CONVERSION | 128.05K | $781.13K | Direct |
| May 21, 26 | SHUKLA ABHINAV A. PH.D. Chief Technology Officer |
STOCK | 5.12K | $31.19K | Direct |
| May 21, 26 | SHUKLA ABHINAV A. PH.D. Chief Technology Officer |
CONVERSION | 5.12K | $31.19K | Direct |
| May 15, 26 | STOUT STEPHEN General Counsel |
STOCK | 12.80K | $80.16K | Direct |
| May 15, 26 | STOUT STEPHEN General Counsel |
CONVERSION | 12.80K | $80.16K | Direct |
| May 12, 26 | PANDITE ARUNDATHY N. Officer |
SELL | 30.00K | $198.30K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ASHIYA MONA |
Director | — | Conversion of Exercise of derivative security |
NEILL ANDREW R. |
Chief Financial Officer | 292.25K | Stock Award(Grant) |
ORBIMED ADVISORS, L.L.C. |
Unknown | — | Purchase |
PANDITE ARUNDATHY N. |
Officer | 136.22K | Sale |
REDMILE GROUP, L.L.C. |
Director and Beneficial Owner of more than 10% of a Class of Security | — | Purchase |
SCHREIBER TAYLOR M.D., PH.D. |
Chief Executive Officer | 2.73M | Stock Award(Grant) |
SHUKLA ABHINAV A. PH.D. |
Chief Technology Officer | 98.53K | Conversion of Exercise of derivative security |
SIEGALL CLAY B |
Director | 318.61K | Purchase |
STOUT STEPHEN |
General Counsel | 93.37K | Stock Award(Grant) |
Moving averages & technicals
SMA 10
7.38
+1.99% from price
SMA 20
7.29
+3.35% from price
SMA 50
6.69
+12.54% from price
SMA 100
6.57
+14.59% from price
SMA 200
5.22
+44.31% from price
EMA 12
7.38
+2.03% from price
EMA 26
7.19
+4.69% from price
EMA 50
6.88
+9.44% from price
RSI (14)
55.6
Neutral
MACD (12,26,9)
0.19
Hist -0.02
ATR (14)
0.47
6.25% of price
Realised vol 30D
70.1%
Annualised
Bollinger upper
7.81
20, 2σ
Bollinger lower
6.76
20, 2σ
50 / 200 cross
Golden
6.69 vs 5.22
Trend bias
Above 200
+44.31%
Risk profile
Beta vs SPY
1.66
More volatile than market
Correlation to SPY
0.23
Largely independent
Realised vol 30D
70.1%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-50.5%
Peak to trough
Max drawdown 5Y
-96.6%
Peak to trough
ATR 14
0.47
6.25% of price
Beta (reported)
1.11
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.12
Call-heavy session
Put / call open interest
0.05
Positioning, not flow
Max pain
2.50
-66.8% from spot
ATM implied vol
91.8%
Nearest strike to spot
Skew (10% OTM)
+488.3%
Puts bid over calls
Call volume
25
Contracts, this expiry
Put volume
3
Contracts, this expiry
Heaviest call OI
5.00
24 contracts
Heaviest put OI
5.00
2 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Shattuck Labs, Inc. (STTK) is a Great Momentum Stock: Should You Buy?
Zacks · 2d ago
Wall Street Analysts Believe Shattuck Labs (STTK) Could Rally 85.31%: Here's is How to Trade
Zacks · 9d ago
Shattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire · 11d ago
Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday
Motley Fool · 29d ago
SpaceX initiated, PayPal upgraded: Wall Street's top analyst calls
The Fly · 29d ago
Here Are Friday’s Top Wall Street Analyst Research Calls: Albertsons, Blue Owl Capital, Cleveland-Cliffs, Chime Financial, Digital Realty, Dover, PayPal Holdings, SpaceX, and More
24/7 Wall St. · 29d ago
JPMorgan Initiates Shattuck Labs at Overweight With $10 Price Target
MT Newswires · 29d ago
Netflix upgraded, Microsoft initiated: Wall Street's top analyst calls
The Fly · 33d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.